How L-Lysine is Produced
Key Pathways:
- Fermentation Using Corynebacterium glutamicum
- Glucose or molasses is fermented by engineered strains of C. glutamicum, which naturally overproduce lysine.
- Genetic modifications block competing pathways (e.g., threonine) and enhance aspartate pathway flux toward lysine.
- Feedstock and Bioprocessing
- Substrates include corn starch hydrolysate, sugarcane molasses, or even wheat-based glucose.
- Downstream processing includes crystallization and separation of L-lysine monohydrochloride (HCl).
- Advanced Optimization
- Use of CRISPR, metabolic flux modeling, and fed-batch fermentation allows high titers (>150 g/L).
- Some producers explore zero-liquid-discharge systems to reduce environmental impact.
Feedstocks: Corn, sugarcane, wheat starch, molasses — all renewable and widely available.
Case Study: Evonik and CJ CheilJedang – L-Lysine Joint Venture (Germany & China)
Highlights:
- Formed CJ Bio (CJ CheilJedang + Evonik) to scale lysine fermentation plants globally.
- Plants in China, Brazil, and the US produce >500,000 tonnes/year of bio-based L-lysine.
- Focused on sustainable animal nutrition with life-cycle verified GHG reductions.
Timeline & Outcome:
- 2009–2011: JV formation; initial plants commissioned in Asia and Europe.
- 2015: Expanded Brazilian production to serve soymeal-based poultry feed.
- 2020–2024: Shifted to carbon-efficient fermentation and precision fermentation platforms.
Global Startups & Producers Working on Bio-based L-Lysine
- Ajinomoto (Japan) – Pioneer in amino acid fermentation with multiple lysine variants.
- Meihua Holdings (China) – Among the largest global lysine exporters.
- CJ Bio (South Korea) – Integrated amino acid and bio-feed systems.
- NovoNutrients (USA) – Produces amino acids like lysine from CO₂ and industrial off-gases.
India’s Position
- India imports most of its lysine (~90–95%), primarily from China and Southeast Asia
- No domestic large-scale bio-lysine plant exists yet, though feasibility studies have been conducted by RCF, IISc Bangalore, and private feed companies.
- India has abundant molasses and corn starch feedstock, and a large poultry and livestock sector, creating strong latent demand.
- National Bio-Economy Mission and PLI schemes could support import substitution.
Commercialization Outlook
Market & Demand
- Global L-lysine market: ~$5.2 billion (2024), CAGR ~6.2%.
- Applications:
- Animal feed supplement (primarily poultry, swine)
- Human nutritional supplements
- Cosmetics, resins, and polymer precursors
- API intermediate in pharmaceuticals
Key Drivers
- Protein fortification in animal diets without antibiotics.
- Demand for plant-based protein supplements.
- Interest in biobased intermediates for polyamides and resins.
- Rising use in bio-based adhesives and coatings.
Challenges to Address
- Price competitiveness with Chinese imports (~$1.3–1.6/kg FOB).
- High energy and aeration costs in fermentation.
- Downstream purification impacts cost and emissions footprint.
- Regulatory hurdles for feed-grade approval in new production units.
Progress Indicators
- 2009–2012: CJ-Evonik joint venture scales global production.
- 2014–2018: Bio-lysine enters non-feed applications (cosmetics, coatings).
- 2020–2023: Interest in carbon-negative amino acid production grows.
- India: R&D at IISc, CFTRI, and some feed manufacturers; no pilot scale yet.
Fermentation-based bio-lysine production is at TRL 9 globally (fully commercial), while India is at TRL 4–5, with efforts in lab-scale R&D and techno-economic assessments underway.
Conclusion
L-Lysine is a flagship product of industrial biotechnology, with a 100% bio-based global supply chain. Its production through microbial fermentation of sugars exemplifies a mature, scalable alternative to petrochemical inputs. With robust international players like Evonik, Ajinomoto, and CJ Bio, L-lysine has achieved cost competitiveness, sustainability, and quality parity. For India, with its significant animal feed demand and abundant feedstock, import substitution through domestic production represents a strategic opportunity — one that could be unlocked through infrastructure investment, policy support, and process optimization.
Wish to have bio-innovations industry or market research support from specialists for climate & environment? Talk to BioBiz team – Call Muthu at +91-9952910083 or send a note to ask@biobiz.in
Expert Consulting Assistance for Indian Bioenergy & Biomaterials
Talk to BioBiz
Call Muthu – 9952910083
Email – ask@biobiz.in
